FDA pharmacologic class
Glucosylceramide Synthase Inhibitor
2 medicines are in FDA's class of glucosylceramide synthase inhibitors: miglustat (Zavesca) and eliglustat (Cerdelga). 1 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are glucosylceramide synthase inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Miglustat | Opfolda, Zavesca, Yargesa | 4 labelers | n/a | No | No current entry | 0 |
| Eliglustat | Cerdelga | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)